Remixtherapeutics
Senior Director, Clinical & Commercial Supply Chain
Watertown, MA . Posted 4 days ago
The role
This person will lead end-to-end supply planning and operational launch readiness for the first commercial product. They will manage clinical and commercial supply strategies, demand forecasting, and CMO management.
What you will do
- Own clinical supply strategy for all portfolio clinical programs
- Own commercial supply strategy, launch readiness, demand planning, and CMO management
- Develop integrated demand/supply plans, manufacturing schedules, and capacity models
- Lead S&OP cadence including monthly supply reviews and risk assessments
- Lead end-to-end inventory management for clinical and commercial supply chains
- Manage external network execution and align campaign plans to forecasts
- Partner with Finance/Accounting for reconciliations, chargebacks, and rebates
- Oversee commercial packaging readiness, serialization, and artwork lifecycle
- Serve as primary contact for packaging, labeling, logistics, and storage vendors
- Build and monitor KPIs and lead continuous improvement of planning tools
Required qualifications
- BA/BS in Supply Chain, Engineering, or Life Sciences
- 15+ years in biotech/pharma supply chain
- 10+ years commercial and/or late-stage launch readiness experience
- Experience within a highly outsourced biotechnology operating model
- Proven experience managing external manufacturing and supply partners
- Strong understanding of GMP/ GDP, regulatory timing impacts on supply, and global distribution logistics
- Advanced planning/analytics skills (Excel and/or supply planning tools)
- Proficiency in Microsoft Office Suite
- Experience with collaborative platforms (e.g., SharePoint, Box)
- Experience with NetSuite inventory systems
- Willingness and ability to travel domestically and internationally as needed
Nice to have
- Advanced degree
Benefits
- Bonus
- Equity
- Benefits
About the company
Remix Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class of medicines that modulate RNA splicing. Headquartered in Watertown, MA, the company is advancing its pipeline with the lead program REM-422.